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Synthesis of substituted benzooxaborinin-1-ols
via palladium-catalysed cyclisation of alkenyl- and
alkynyl-boronic acids†
Laure Benhamou,* Daniel W. Walker, Dejan-Krešimir Bučar, Abil E. Aliev and
Tom D. Sheppard*
Two new palladium-catalysed reactions have been developed for
the synthesis of stable 4-substituted benzooxaborinin-1-ols.
A palladium-catalysed cyclisation of ortho-alkenylbenzene boronic
acids can be used to access 4-chlorobenzooxaborinin-1-ols via a
Wacker-type oxidation and chlorination. Alternatively, ortho-
alkynylbenzene boronic acids undergo a palladium-catalysed
oxyallylation reaction to provide 4-allylbenzooxaborinin-1-ols.
Organoboron compounds are widely used in organic chem-
istry, most notably in metal-catalysed reactions.1 More recently,
however, organoboron compounds have found applications in
a diverse array of areas including direct amidation reactions,2
novel materials,3 and as sensors for chemical biology.1,4 To
date, however, there are relatively few applications of organo-
boron compounds in medicinal chemistry.1 There are never-
theless an increasing number of “boron therapeutics”
beginning to emerge,5 including peptidomimetics such as
Bortezomib (Fig. 1) and cluster structures for application in
neutron capture therapy.6 More recently, boron-containing
heterocycles have attracted considerable synthetic interest,7 with
benzooxaboroles such as Tavaborole proving to be potentially
interesting scaﬀolds for a range of medicinal chemistry
applications.5,8 In this paper, we describe novel synthetic
approaches to 4-substituted benzooxaborinin-1-ols, a novel
class of boron–oxygen heterocycles, which has potential appli-
cations as a new heterocyclic framework for medicinal chem-
istry or materials science. Whilst benzooxaborinin-1-ols have
appeared in scattered reports over the past 50 years,9 little
attention has been devoted to the development of new syn-
thetic methods for accessing substituted derivatives. The
related 9-Bora-10-oxa-phenanthrene ring system, containing
an additional fused benzene ring, has attracted considerably
more attention10 due to its application as a building block in
the synthesis of o-phenylenes.11
Our group has a long-standing interest in organoboron
chemistry and we have reported an eﬀective method for the
gold-catalysed synthesis of 3-substituted benzooxaborinin-1-
ols from o-alkynylbenzene boronic acids (Scheme 1a).12 Unfor-
tunately, these heterocycles showed relatively low stability due
to the highly electron-rich C-4 position,12,13 limiting their
potential application as heterocyclic scaﬀolds. In order to
address this issue, we envisioned that the introduction of a
substituent at the C-4 position should increase the stability of
the ring system. In this paper, we present two new approaches
to substituted benzooxaborinin-1-ols: (1) palladium-catalysed
Wacker-type cyclisation of o-alkenylbenzene boronic acids14
(Scheme 1b); and (2) palladium-catalysed oxyallylation of
o-alkynylbenzene boronic acids (Scheme 1c). In the first case
(Scheme 1b), we envisaged a process similar to the Wacker oxi-
dation. Palladium(II) catalysts are well known to activate
carbon–carbon double bonds, and have been applied exten-
sively to the oxidation of alkenes.15 Pd-catalysed cyclisation of
an o-alkenylbenzene boronic acid should occur via formation
of an alkylpalladium intermediate which will undergo β-H
elimination to aﬀord the heterocycle. For the second strategy
we envisaged that Pd(II)-catalysed cyclisation of an alkynyl-
boronic acid (Scheme 1c) would give an alkenylpalladium(II)
intermediate.16 This vinyl-palladium intermediate can
Fig. 1 Boron-containing compounds in medicinal chemistry.
†Electronic supplementary information (ESI) available: Full experimental pro-
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subsequently be trapped by an electrophile to aﬀord a sub-
stituted benzooxaborin-1-ol.
To explore the proposed intramolecular oxidative cyclisa-
tion, we used commercially available 2-vinylbenzene boronic
acid 1a as a test substrate. In the presence of a stoichiometric
amount of Pd(CH3CN)2Cl2, the boronic acid underwent cyclisa-
tion to aﬀord the benzooxaborin-1-ol 2a as the sole product.
Various sources of palladium(II) were also screened but none
proved to be as eﬃcient as Pd(CH3CN)2Cl2.
17 We then sought
to develop a catalytic method using an oxidant to regenerate
the Pd(II) active species, and copper(II) chloride proved most
eﬀective.17 As often observed in Wacker-type oxidations,15
solvent appeared to be a crucial parameter. Typical polar
solvents commonly used in Pd(II)-catalysed oxidations,14 such
as DMSO, acetonitrile and dioxane inhibited the reaction, even
with stoichiometric quantities of Pd(II), presumably due to
coordination to the metal centre which reduces the activity of
the catalyst. However, the boronic acid 1a and copper(II) chlor-
ide are both highly insoluble in apolar solvents (PhMe,
CH2Cl2, CPME) resulting in very low conversion and trimerisa-
tion of 1a to form the boroxine. Pleasingly, tert-butanol proved
an eﬀective solvent for the reaction, most likely by providing a
balance between solubility of the reaction partners, reactivity
and stabilisation of the metal centre. In the end the optimised
parameters aﬀorded 2a in 71% isolated yield (Scheme 2). An
attempt to decrease the catalyst loading from 5 to 2 mol%
resulted in a significantly reduced yield (39%). Finally, we also
explored the use of catalytic amounts of palladium(II) and
copper(II) chloride under aerobic conditions (1 atm. O2),
which gave 2a in 30% yield.
With conditions in hand, we extended the reaction to other
substrates (Scheme 3). We were pleased to find that 1b also
underwent cyclisation. However the reaction produced a
mixture of benzooxaborinin-1-ol 2b and 4-chloro-benzo-
oxaborinin-1-ol 3b which were inseparable by chromatography.
This issue was addressed by treatment of the mixture of 2b/3b
with one equivalent of CuCl2 in tert-butanol to aﬀord a pure
sample of 4-chlorobenzooxaborininol 3b in moderate yield
over the two steps (58%). Arylsubstituted alkene 1c was less
reactive, necessitating an increase in catalyst loading and a
longer reaction time to aﬀord the chloro-oxaborine 3c in 34%
yield (Scheme 3), or 45% at 60 °C.
In order to explore the direct synthesis of a 4-alkyl benzo-
oxaborin-1-ol, we examined the cyclisation of boronic acid 1d
(Scheme 4). This compound was also less reactive under the
standard conditions, with a longer reaction time and a higher
catalyst loading being required to observe full conversion of
the starting material. Interestingly, the formation of the
expected product 2d was not observed, with the major product
arising from the reaction being the chloride 3b (67% isolated
yield). In addition, traces of 1,1-dimethylbenzooxaborole 4d
were observed. The formation of 3b could potentially be
explained by cationic rearrangement of the possible reaction
intermediate 5. The chlorinated benzooxaborinin-1-ols 3b–3c
Scheme 2 Pd-catalysed cyclisation of 2-vinylbenzene boronic acid 1a.
Scheme 3 Pd-catalysed cyclisation/chlorination of internal alkenes.
Scheme 4 Pd-catalysed cyclisation/chlorination of a 1,1-disubstituted
alkene.
Scheme 1 Metal-catalysed approaches to benzooxaborinin-1-ols.
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are formally halogenated boron enolates, a class of com-
pounds that has never previously been structurally charac-
terised.18 Importantly, however, the presence of the chlorine
atom at C4 increases the stability of the benzooxaborinin-1-ol
ring system, and these compounds are air and moisture stable
and can readily be isolated. We hypothesised that the copper(II)
chloride co-oxidant was responsible for the chlorination of
the ring, and to confirm this we examined direct halogenation
of benzooxaborinin-1-ol 2e (Table 1, entry 1), prepared via
gold-catalysed cyclisation of the corresponding o-alkynylbenzene-
boronic acid.12 Pleasingly, the chlorinated compound 3e
was obtained from 2e in good yield, upon treatment with
copper(II) chloride (2 eq.) in t-BuOH; N-chlorosuccinimide
(1 eq.) was also eﬀective for this transformation (entry 2),
though gave a lower yield. When copper(II) bromide was used,
the brominated benzooxaborinin-1-ol (Br-3e) was obtained in
63% yield (entry 3).
The position of the chlorine atom in 3e was unambiguously
determined by 13C{1H} NMR, where the signal corresponding
to the C4 carbon (δC 114.2 ppm) showed a slight splitting due
to the two chlorine isotopes (35Cl and 37Cl).19 Subsequently,
the solid state structure was confirmed by singly crystal X-ray
diﬀraction (Fig. 2). As previously reported for analogous
boron–oxygen heterocycles the pseudo-naphthalene core is a
planar framework with a small degree of delocalization
between the two rings.7a The terminal B–O bond (1.3642(19)
and 1.3615(18)) appears slightly shorter than the endocyclic
B–O bond (1.3802(17) and 1.3791(18)), but both are similar to
the B–O bond in a boronic acid.20 The phenyl ring at C-3 is
clearly tilted away from the heterocyclic plane suggesting little
conjugation between these two fragments (torsion angle
C7–C8–C9–C10 and C21–C22–C23–C24 of 45° and 49°, respec-
tively). Such distortion could be due to steric repulsion
between the phenyl ring and the chlorine atom.
We envisioned that the benzooxaborole by-product 4d,
obtained during the Pd-mediated cyclisation of 1d, was prob-
ably formed due to the hydrochloric acid released during the
Wacker type oxidation process (Scheme 1), which could cata-
lyse a formal intramolecular hydration of the alkene. Indeed,
when substrate 1d was stirred in the presence of Amberlyst 15,
the heterocyclic compound 4d was obtained in 55% yield
(Table 2, entry 1). By using a stoichiometric amount of HCl
(generated from addition of Me3SiCl) only a low conversion to
compound 1d was seen after 24 hours (entry 2). Arylalkene 1c
did not cyclise with a Brønsted acid (entry 3), but in the pres-
ence of catalytic platinium(IV) chloride, both 1c and 1d were
converted into the corresponding benzooxaboroles (entries 5
and 6).
As the Wacker-type oxidation procedure did not allow us to
access benzooxaborininols bearing a carbon substituent at C4,
we wished to explore alternative strategies. With this in mind,
we were inspired by a recently reported cyclisation/allylation of
alkenyl alcohols by palladium-catalysed reaction with allyl
chlorides.21 We therefore sought to apply this reaction to the
allylative cyclisation of o-alkynylbenzeneboronic acids
(Table 3). Once again, tert-butanol proved to be the solvent of
choice for this transformation, with more polar solvents inhi-
biting the reaction. The best conversion was obtained using
5 mol% of Pd(PhCN)2Cl2 as catalyst at 30 °C, and the presence
of a mild base (NaHCO3) and 5 equivalents of allyl chloride 7a
were required to avoid competing proto-demetallation to give
the unsubstituted benzooxaborininol. Under these conditions,
aromatic substituents on the alkyne were well tolerated and
Table 1 Halogenation of oxaborines (2e)
Entry Oxidant Eq. [O] Solvent T (°C) Yields
1 CuCl2 2 tBuOH 30 82
2 NCS 1 CH3CN R.T. 61
3 CuBr2 2 tBuOH 30 63
Fig. 2 X-ray crystal structure of the asymmetric unit of 4-chlorobenzo-
oxaborin-1-ol 3e. Ellipsoids are shown at the 50% probability level.
Only the hydrogen atom bonded to O2 and O4 are shown for clarity.
Selected interatomic distances (Å) and bond angles (°): C6–C7 1.4613(19);
C7–C8 1.3492(19); C8–O1 1.3786(16); O1–B1 1.3802(17); B1–O2
1.3642(19); C1–B1 1.529(2); C7–Cl1 1.7378(13); C7–C8–C9 129.55(12);
C20–C21 1.4580(19); C21–C22 1.3473(19); C22–O3 1.3729(15); O3–B2
1.3791(18); B2–O4 1.3615(18); C15–B1 1.533(2); C21–Cl2 1.7454(13);
C21–C22–C23 128.96(12).
Table 2 Acid-catalysed formation of benzoboroles 4c and 4d
Entry Method Substrate R1 R2 Yield (%)
1 Aa 1d Me H 55
2 Bb 1d Me H 10c
3 A 1c H pTol 0
4 Cd 1d Me H 51
5 C 1c H pTol 24e
a Amberlyst 15. b 2 eq. of TMSCl. cNMR yield. d 10 mol% PtCl4 in
CH2Cl2, R.T., 12 hours.
eOvernight.
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the 4-allylbenzooxaborininols 9a–9e were prepared in moder-
ate to good yields (entries 1–5). Several allyl chlorides were
then screened to determine the scope of the reaction with
regard to the C-4 substituent. We were pleased to see that
terminal allyl chlorides 8a–8c (entries 1–3) were excellent coup-
ling partners for this transformation. In comparison, internal
allyl chloride 8d required higher temperature (50 °C) to give a
modest yield. Importantly, however, the use of the branched
allyl chloride 8c gave the linear product 9c, whereas linear allyl
chloride 8d led to the exclusive formation of the branched
product 9e. Whilst arylsubstituted alkynes worked well in the
reaction, terminal and alkyl-substituted alkynes were some-
what prone to competitive proto-demetallation which resulted
in an inseparable mixture of allylated product and the corres-
ponding 4-H benzooxaborininol (entries 6 and 7).
In conclusion, we have developed new palladium-catalysed
reactions for the preparation of 4-substituted-benzooxa-
borinols. The transformations occur under mild conditions
using tert-butanol as solvent, which was crucial for enabling
eﬀective catalytic turnover of the palladium whilst maintaining
suﬃcient catalyst reactivity. Firstly, a Wacker type oxidation of
o-alkenylbenzeneboronic acids allowed the preparation of
previously unreported 4-chlorobenzooxaborininols, which
could also be accessed by direct halogenation of the parent
4-H benzooxaborininols. In parallel, careful analysis of the
by-products generated during this reaction led to the discovery
of a new route to benzooxaboroles. We have also developed a
palladium catalyzed cyclisation/allylation of alkynylbenzene
boronic acids to aﬀord 4-allyl-benzooxaborininols. Thus, the
two synthetic routes provide complementary approaches to
diﬀerent classes of 4-substituted benzooxaborininols. Finally,
our study has successfully demonstrated that addition of a
substituent at C-4 of this unusual boron/oxygen heterocycle
greatly increases the stability of the compounds, making them
a potentially attractive new heterocyclic ring system for use in
medicinal chemistry.
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Sciences Research Council (Grant reference EP/K001183/1) for
supporting this work. We would also like to acknowledge the
EPSRC National Mass Spectrometry Facility at Swansea
University for providing analytical services.
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